Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis
In this cohort study, LDS was a rare clinical manifestation in patients with SSc but was associated with pulmonary hypertension. Therefore, patients with LDS should be closely monitored and screened for pulmonary hypertension.
Authors
- Leland W.K. Chung (ORCID: https://orcid.org/0000-0003-0072-6939)
- Matthew A. Lewis (ORCID: https://orcid.org/0000-0002-3714-9031)
- David Fiorentino (ORCID: https://orcid.org/0000-0001-7951-3674)
- Srijana Davuluri (ORCID: https://orcid.org/0000-0002-6332-2491)
- Puneet Kapoor
- Julia F. Simard (ORCID: https://orcid.org/0000-0001-5735-9856)
- Shufeng Li (ORCID: https://orcid.org/0000-0001-6031-0893)
- Swarna Nandyala
Institutions
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1001/jamadermatol.2024.3929
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00